Viridian Therapeutics, Inc.\DE Quarterly Entity Common Stock, Shares Outstanding from Q2 2014 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Viridian Therapeutics, Inc.\DE quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2014 to Q2 2024.
  • Viridian Therapeutics, Inc.\DE Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 63.9M shares, a 46.3% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 63.9M +20.2M +46.3% Aug 5, 2024 10-Q 2024-08-08
Q1 2024 63.8M +20.9M +48.8% May 1, 2024 10-Q 2024-05-08
Q3 2023 52.6M +12.3M +30.7% Nov 7, 2023 10-Q 2023-11-13
Q2 2023 43.7M +15.2M +53.4% Aug 7, 2023 10-Q 2023-08-08
Q1 2023 42.9M +17M +65.5% Mar 3, 2023 10-K 2023-03-09
Q3 2022 40.2M +18.5M +85.3% Nov 9, 2022 10-Q 2022-11-14
Q2 2022 28.5M +18.9M +197% Aug 10, 2022 10-Q 2022-08-15
Q1 2022 25.9M +18.7M +258% Mar 7, 2022 10-K 2022-03-11
Q3 2021 21.7M -36.9M -63% Nov 3, 2021 10-Q 2021-11-05
Q2 2021 9.59M -47M -83.1% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 7.23M -45.8M -86.4% Mar 18, 2021 10-K 2021-03-26
Q3 2020 58.7M +26.9M +84.5% Nov 6, 2020 10-Q 2020-11-12
Q2 2020 56.6M +25.6M +82.3% Jul 29, 2020 10-Q 2020-08-05
Q1 2020 53.1M +22.1M +71.6% Mar 2, 2020 10-K 2020-03-13
Q3 2019 31.8M +949K +3.08% Nov 4, 2019 10-Q 2019-11-08
Q2 2019 31M +448K +1.46% Aug 2, 2019 10-Q 2019-08-08
Q1 2019 30.9M +749K +2.48% Mar 7, 2019 10-K 2019-03-14
Q3 2018 30.8M +8.53M +38.2% Oct 31, 2018 10-Q 2018-11-07
Q2 2018 30.6M +9.11M +42.4% Aug 1, 2018 10-Q 2018-08-08
Q1 2018 30.2M +8.8M +41.2% Mar 12, 2018 10-K 2018-03-15
Q3 2017 22.3M +11.5M +107% Nov 2, 2017 10-Q 2017-11-09
Q2 2017 21.5M +10.7M +99.1% Aug 3, 2017 10-Q 2017-08-11
Q1 2017 21.4M +10.7M +99.6% Mar 17, 2017 10-K 2017-03-24
Q3 2016 10.8M +155K +1.46% Oct 20, 2016 10-Q 2016-10-26
Q2 2016 10.8M +2.92M +37.1% Aug 12, 2016 10-Q 2016-08-15
Q1 2016 10.7M +3.2M +42.7% Mar 15, 2016 10-K 2016-03-21
Q3 2015 10.6M +6.85M +181% Nov 6, 2015 10-Q 2015-11-13
Q2 2015 7.87M +4.09M +108% Aug 5, 2015 10-Q 2015-08-14
Q1 2015 7.5M Mar 15, 2015 10-K 2015-03-27
Q3 2014 3.78M Nov 14, 2014 10-Q 2014-11-14
Q2 2014 3.78M Aug 14, 2014 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.